Hepatitis A vaccine: patient group direction (PGD) template
PGD template to support the provision of hepatitis A vaccine to individuals pre- and post-exposure to hepatitis A.
- From:
-
UK Health Security Agency
PublishedPublished:- 13 November 2017
- Last
updatedupdated: -
10- 30
OctoberSeptember2023 - 30
Applies to England
Documents
Hepatitis A vaccine: patient group direction template
Ref: UKHSA publications gateway number GOV-15398
MS Word Document, 166248 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
The Hepatitis A vaccine patient group direction (PGD) version 5.006.0 is valid from 31 October 20232026 to 31 October 2026.2029.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
Published 13 November 2017
Last updated 1030 OctoberSeptember 2023
+ show2026
—
Show all updates
-
Sign up for emails or print this page
Hepatitis A vaccine: patient group direction template
Ref: UKHSA publications gateway number GOV-15398
MS Word Document, 166248 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
The Hepatitis A vaccine patient group direction (PGD) version 5.006.0 is valid from 31 October 20232026 to 31 October 2026.2029.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
Published 13 November 2017
Last updated 1030 OctoberSeptember 2023
+ show2026
—
Show all updates
-
Sign up for emails or print this page
Details
The Hepatitis A vaccine patient group direction (PGD) version 5.006.0 is valid from 31 October 20232026 to 31 October 2026.2029.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.